About Alsonex
Alsonex is a company based in Brisbane (Australia) founded in 2014 by Brandon D Lewis and David Groth. It operates as a B2B. Alsonex offers products and services including ALS-205. Alsonex operates in a competitive market with competitors including Biogen, Denali Therapeutics, Intra-Cellular Therapies, Amylyx Pharmaceuticals and Annexon, among others.
- Headquarter Brisbane, Australia
- Founders Brandon D Lewis, David Groth
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Alsonex Pty Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alsonex
Alsonex offers a comprehensive portfolio of products and services, including ALS-205. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatment compound for Motor Neuron Disease and other conditions.
Funding Insights of Alsonex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Alsonex
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alsonex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alsonex Comparisons
Competitors of Alsonex
Alsonex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, Denali Therapeutics, Intra-Cellular Therapies, Amylyx Pharmaceuticals and Annexon, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for psychiatric and neurologic diseases
|
|
| domain | founded_year | HQ Location |
Small-molecule therapeutics for neurodegenerative diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Biologics platform developed for intracellular delivery in rare diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Alsonex
When was Alsonex founded?
Alsonex was founded in 2014.
Where is Alsonex located?
Alsonex is headquartered in Brisbane, Australia. It is registered at Brisbane, Queensland, Australia.
What does Alsonex do?
Alsonex is a biopharmaceutical company dedicated to creating innovative treatments for neurodegenerative diseases like Parkinsons, Alzheimers, Huntingtons, and Motor Neuron Disease. Founded in 2014 from research at the University of Queensland, it advances products to proof-of-concept stages and collaborates with larger firms for clinical trials. Based in Brisbane, Australia, the company focuses on drug development while sharing risks to enhance shareholder value through targeted therapies.
Who are the top competitors of Alsonex?
Alsonex's top competitors include Alector, Intra-Cellular Therapies and Entrada Therapeutics.
What products or services does Alsonex offer?
Alsonex offers ALS-205.